Hyperandrogenism in Women with Polycystic Ovarian Syndrome: Pathophysiology and Controversies

41Citations
Citations of this article
201Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Polycystic ovary syndrome (PCOS) is an essential differential diagnosis of hyperandrogenism to consider in women, with most women presenting with irregular menses, infertility, and hirsutism. The diagnosis is challenging because it is a heterogenous disorder with significant variations in its associated features. Classic PCOS (hyperandrogenism plus ovulatory dysfunction) affects about 10% of reproductive-Age women. Hyperandrogenism (clinical, biochemical, or both) is a hallmark of the syndrome. Approximately 60-76% of PCOS women are hirsute and hyperandrogenemia is observed in 75-90% of these women. Androgen assays are not always reliable at the lower levels detected in women with PCOS. This article will attempt to review the pathophysiology and controversies of hyperandrogenism in PCOS women, its clinical and biochemical presentations, and management.

Cite

CITATION STYLE

APA

Kanbour, S. A., & Dobs, A. S. (2022). Hyperandrogenism in Women with Polycystic Ovarian Syndrome: Pathophysiology and Controversies. Androgens, 3(1), 22–30. https://doi.org/10.1089/andro.2021.0020

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free